Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study

Erstveröffentlichung
2006Authors
Engert, A
Bredenfeld, H
Döhner, Hartmut
Ho, AD
Schmitz, N
Wissenschaftlicher Artikel
Published in
Haematologica, the hematology journal ; 91 (2006), 4. - S. 546-549. - ISSN 0390-6078
Institutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: Hodgkin's lymphoma | chemotherapy | phase I | colony-stimulating factor | daily filgrastim | disease | neutropenia | multicenter | standard | cancer | cycle[DDC subject group]: DDC 610 / Medicine & health